Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression

The study of cancer biology has mainly focused on malignant epithelial cancer cells, although tumors also contain a stromal compartment, which is composed of stem cells, tumor-associated fibroblasts (TAFs), endothelial cells, immune cells, adipocytes, cytokines, and various types of macromolecules comprising the extracellular matrix (ECM). The tumor stroma develops gradually in response to the needs of epithelial cancer cells during malignant progression initiating from increased local vascular permeability and ending to remodeling of desmoplastic loosely vascularized stromal ECM. The constant bidirectional interaction of epithelial cancer cells with the surrounding microenvironment allows damaged stromal cell usage as a source of nutrients for cancer cells, maintains the stroma renewal thus resembling a wound that does not heal, and affects the characteristics of tumor mesenchymal stem/stromal cells (MSCs). Although MSCs have been shown to coordinate tumor cell growth, dormancy, migration, invasion, metastasis, and drug resistance, recently they have been successfully used in treatment of hematopoietic malignancies to enhance the effect of total body irradiation-hematopoietic stem cell transplantation therapy. Hence, targeting the stromal elements in combination with conventional chemotherapeutics and usage of MSCs to attenuate graft-versus-host disease may offer new strategies to overcome cancer treatment failure and relapse of the disease.

[1]  竹田 昌彦.  Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression , 2018 .

[2]  Manran Liu,et al.  Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression. , 2015, Cancer letters.

[3]  V. Heinemann,et al.  Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial , 2015, BMC Cancer.

[4]  T. Kalber,et al.  Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors , 2015, The Journal of Immunology.

[5]  A. Gemma,et al.  Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth , 2015, Oncotarget.

[6]  W. Woodward,et al.  Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model , 2015, Breast Cancer Research.

[7]  Stephen T. C. Wong,et al.  Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model. , 2015, Cell reports.

[8]  Camille Stephan-Otto Attolini,et al.  Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.

[9]  G. Inghirami,et al.  Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.

[10]  M. Bhasin,et al.  MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. , 2014, Cell stem cell.

[11]  N. Cho,et al.  Cancer‐associated fibroblast promote transmigration through endothelial brain cells in three‐dimensional in vitro models , 2014, International journal of cancer.

[12]  Jun Chen,et al.  Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications. , 2014, Cancer letters.

[13]  R. Weinberg,et al.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis , 2014, Nature Cell Biology.

[14]  P. Rameshwar,et al.  Treg/Th17 polarization by distinct subsets of breast cancer cells is dictated by the interaction with mesenchymal stem cells. , 2014, Journal of cancer stem cell research.

[15]  J. Bouchal,et al.  The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance , 2014, Cancer Cell International.

[16]  J. Rak,et al.  Genetic Basis of Thrombosis in Cancer , 2014, Seminars in Thrombosis & Hemostasis.

[17]  J. Kurtzberg,et al.  Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  A. Godwin,et al.  Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion , 2013, Proceedings of the National Academy of Sciences.

[19]  Feng Yu,et al.  A Vaccine That Co-Targets Tumor Cells and Cancer Associated Fibroblasts Results in Enhanced Antitumor Activity by Inducing Antigen Spreading , 2013, PloS one.

[20]  S. Kaul,et al.  Mortalin antibody-conjugated quantum dot transfer from human mesenchymal stromal cells to breast cancer cells requires cell-cell interaction. , 2013, Experimental cell research.

[21]  B. Niederle,et al.  Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis , 2013, Virchows Archiv.

[22]  C. Verfaillie,et al.  Mesenchymal Stem Cells Migration Homing and Tracking , 2013, Stem cells international.

[23]  S. Corso,et al.  Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective. , 2013, Cancer discovery.

[24]  R. Stahel,et al.  Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells , 2013, Journal of Translational Medicine.

[25]  A. Schambach,et al.  Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo. , 2013, Stem cells and development.

[26]  A. Soricelli,et al.  Brief Report: Mesenchymal Stromal Cell Atrophy in Coculture Increases Aggressiveness of Transformed Cells , 2013, Stem cells.

[27]  J. Wrana,et al.  Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration , 2012, Cell.

[28]  Kunwei Shen,et al.  Stromal cells in tumor microenvironment and breast cancer , 2012, Cancer and Metastasis Reviews.

[29]  King-Jen Chang,et al.  Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway. , 2012, Cancer research.

[30]  G. van der Pluijm,et al.  Epithelial Plasticity, Cancer Stem Cells, and the Tumor-Supportive Stroma in Bladder Carcinoma , 2012, Molecular Cancer Research.

[31]  H. Haller,et al.  Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. , 2012, Stem cells and development.

[32]  G. Rappa,et al.  Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. , 2012, The American journal of pathology.

[33]  G. Fishman,et al.  Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells , 2012, Proceedings of the National Academy of Sciences.

[34]  E. Vairaktaris,et al.  The interplay between hemostasis and malignancy: the oral cancer paradigm. , 2012, Anticancer research.

[35]  D. Banerjee,et al.  Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion , 2012, PloS one.

[36]  S. Richardson,et al.  Bi-Directional Exchange of Membrane Components Occurs during Co-Culture of Mesenchymal Stem Cells and Nucleus Pulposus Cells , 2012, PloS one.

[37]  H. Dvorak,et al.  Vascular hyperpermeability, angiogenesis, and stroma generation. , 2012, Cold Spring Harbor perspectives in medicine.

[38]  C. Kunder,et al.  Mast cell modulation of the vascular and lymphatic endothelium. , 2011, Blood.

[39]  Kathleen R. Cho,et al.  Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. , 2011, The Journal of clinical investigation.

[40]  H. Dvorak,et al.  Orphan nuclear transcription factor TR3/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctions , 2011, Proceedings of the National Academy of Sciences.

[41]  A. Jimeno,et al.  Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy , 2011, Nature Medicine.

[42]  B. Niederle,et al.  Desmoplastic stromal reaction in papillary thyroid microcarcinoma , 2011, Histopathology.

[43]  Andreas Trumpp,et al.  Bridging the information gap , 2011, Nature Immunology.

[44]  Steven J. Greco,et al.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.

[45]  X.L. Lu,et al.  α-Tocopherol Treatment Ameliorates Chronic Pancreatitis in an Experimental Rat Model Induced by Trinitrobenzene Sulfonic Acid , 2011, Pancreatology.

[46]  G. Dontu,et al.  Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. , 2011, Cancer research.

[47]  M. Andreeff,et al.  Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.

[48]  W. Woodward,et al.  Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells , 2010, PloS one.

[49]  A. Vincent-Salomon,et al.  Oxidative stress promotes myofibroblast differentiation and tumour spreading , 2010, EMBO molecular medicine.

[50]  F. Baron,et al.  Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[51]  Ruth S. Waterman,et al.  A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.

[52]  J. Seoane,et al.  Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis. , 2009, Experimental cell research.

[53]  M. Andreeff,et al.  Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.

[54]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[55]  K. Burridge,et al.  The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species* , 2009, The Journal of Biological Chemistry.

[56]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[57]  A. Gemma,et al.  Clinicopathological analysis of primary lung carcinoma with heterotopic ossification. , 2009, Lung cancer.

[58]  A. Kate Sasser,et al.  Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.

[59]  M. Stella,et al.  The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis. , 2008, Molecular biology of the cell.

[60]  R. Cardiff,et al.  SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. , 2008, Cancer research.

[61]  J. Gilabert-Estellés,et al.  Fibrinolysis: the key to new pathogenetic mechanisms. , 2008, Current medicinal chemistry.

[62]  W. Woodward,et al.  Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. , 2007, Cancer research.

[63]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[64]  C. Haslinger,et al.  Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. , 2007, International journal of oncology.

[65]  E. Lam,et al.  Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth , 2007, Leukemia.

[66]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[67]  R. Reed,et al.  Inhibition of carcinoma cell‐derived VEGF reduces inflammatory characteristics in xenograft carcinoma , 2006, International journal of cancer.

[68]  M. Loeffler,et al.  Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.

[69]  Lindolfo da Silva Meirelles,et al.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.

[70]  K. Kaczirek,et al.  Desmoplastic Stromal Reaction in Medullary Thyroid Cancer—An Intraoperative “Marker” for Lymph Node Metastases , 2006, World Journal of Surgery.

[71]  R. Jain,et al.  Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. , 2006, Blood.

[72]  Darwin J. Prockop,et al.  Mitochondrial transfer between cells can rescue aerobic respiration , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[73]  A. Gansmuller,et al.  Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. , 2005, Cancer research.

[74]  E. Gilboa,et al.  Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. , 2005, Cancer research.

[75]  C. Dermardirossian,et al.  GDIs: central regulatory molecules in Rho GTPase activation. , 2005, Trends in cell biology.

[76]  Andrea Bacigalupo,et al.  Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[77]  V. Pellegrini,et al.  The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: An animal model in the rabbit , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[78]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[79]  K. Ohuchida,et al.  Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. , 2004, Cancer research.

[80]  Y. Rao,et al.  Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[81]  Xiaochong Wu,et al.  Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. , 2003, Cancer research.

[82]  S. Larson,et al.  A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[83]  T. Joh,et al.  Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. , 2003, Gastroenterology.

[84]  D. Jäger,et al.  Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer , 2003, Oncology Research and Treatment.

[85]  G. Ayala,et al.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[86]  M. Andreeff,et al.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.

[87]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[88]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[89]  K. Pfizenmaier,et al.  Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas , 2001, International journal of cancer.

[90]  R K Jain,et al.  Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Little,et al.  Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[92]  G. Beatty,et al.  IFN-γ Can Promote Tumor Evasion of the Immune System In Vivo by Down-Regulating Cellular Levels of an Endogenous Tumor Antigen1 , 2000, The Journal of Immunology.

[93]  H. Geuze,et al.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.

[94]  A. Jackson,et al.  Induction of microsatellite instability by oxidative DNA damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[95]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[96]  J. Foekens,et al.  Stromal influences on breast cancer cell growth. , 1992, British Journal of Cancer.

[97]  V. Bertone,et al.  Stroma formation in Ehrlich carcinoma. I. Oedema phase. A mitosis burst as an index of physiological reoxygenation? , 1991, Anticancer research.

[98]  D. McKay.  [3H]Noradrenaline accumulation in cultured bovine adrenal medullary cells: modulation of accumulation by nicotine , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

[99]  D. McEachern,et al.  Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts. , 1989, Cancer research.

[100]  H. Dvorak,et al.  Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. , 1989, Biochimica et biophysica acta.

[101]  H. Dvorak,et al.  Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[102]  D. Zipori,et al.  Stromal cell effects on clonal growth of tumors , 1987, Cancer.

[103]  A Ahmed,et al.  Stromal changes in invasive breast carcinoma: An ultrastructural study , 1987, The Journal of pathology.

[104]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[105]  K. Mann,et al.  Tumor cell generation of thrombin via functional prothrombinase assembly. , 1985, Cancer research.

[106]  Gary R. Grotendorst,et al.  Increased content of Type V Collagen in desmoplasia of human breast carcinoma. , 1982, The American journal of pathology.

[107]  E. Manseau,et al.  Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. , 1979, Journal of the National Cancer Institute.

[108]  H. Dvorak,et al.  Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. , 1979, Journal of immunology.

[109]  J. Papadimitriou,et al.  The effect of inflammatory stimuli on the stroma of neoplasms: The involvement of mononuclear phagocytes , 1977, The Journal of pathology.

[110]  H. Lazarus,et al.  GROWTH CHARACTERISTICS OF VIRUS-TRANSFORMED CELLS , 1970, The Journal of experimental medicine.

[111]  M. Greenblatt,et al.  Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. , 1968, Journal of the National Cancer Institute.

[112]  I. Levin.  THE MECHANISMS OF METASTASIS FORMATION IN EXPERIMENTAL CANCER , 1913, The Journal of experimental medicine.

[113]  I. Levin.  CHANGES IN THE TISSUE SURROUNDING A GROWING TUMOR AND THE SIGNIFICANCE OF THE "PRECANCEROUS STATE." , 1912, The Journal of experimental medicine.

[114]  E. R. Le Count.  LYMPHOMA, A BENIGN TUMOR REPRESENTING A LYMPH GLAND IN STRUCTURE , 1899, The Journal of experimental medicine.

[115]  P. Rameshwar,et al.  Treg / Th 17 polarization by distinct subsets of breast cancer cells is dictated by the interaction with mesenchymal stem cells , 2014 .

[116]  M. McNiven.  Breaking away: matrix remodeling from the leading edge. , 2013, Trends in cell biology.

[117]  Kenneth M. Yamada,et al.  Direct visualization of protease activity on cells migrating in three-dimensions. , 2009, Matrix Biology.

[118]  J. Wagner,et al.  Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial , 2009, Bone Marrow Transplantation.

[119]  P. Gumerlock,et al.  Molecular biology of prostate cancer , 2004, World Journal of Urology.

[120]  久野 篤.  Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats , 2004 .

[121]  J. Ringel,et al.  Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. , 2001, Cancer research.

[122]  J. Ringel,et al.  Transforming Growth Factor-β1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma , 2001 .

[123]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.

[124]  F. Jänicke,et al.  Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. , 1992, Biological chemistry Hoppe-Seyler.

[125]  M. Abercrombie.  The bases of the locomotory behaviour of fibroblasts. , 1961, Experimental cell research.